Epstein Barr virus (EBV)

• Health & Medicine

Women in science: Cancer research pioneers – part 2

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

25 January 2023

• Health & Medicine

Cancer Research UK launches trial to fight cancer caused by a common virus

Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV). Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).

25 March 2014

• Health & Medicine

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year. A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.

24 March 2014